ASX:OSX Osteopore Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Osteopore Limited Please log in to your account or sign up in order to add this asset to your watchlist. Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlines Receive OSX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Osteopore and its competitors with MarketBeat's FREE daily newsletter. Email Address OSX Stock Forecast (MarketRank)Overall MarketRank™0.33 out of 5 starsAnalyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Osteopore. Previous Next 0.0 Community Rank Outperform VotesOsteopore has received 0 “outperform” votes. (Add your “outperform” vote.)Underperform VotesOsteopore has received 0 “underperform” votes. (Add your “underperform” vote.)MarketBeat's community ratings are surveys of what our community members think about Osteopore and other stocks. Vote “Outperform” if you believe OSX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OSX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldOsteopore does not currently pay a dividend.Dividend GrowthOsteopore does not have a long track record of dividend growth. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Osteopore insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$15,500.00 in company stock and sold A$0.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here About OsteoporeOsteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. Osteopore Limited was incorporated in 2003 and is headquartered in Singapore.Read More OSX Stock News HeadlinesJune 19, 2022 | americanbankingnews.comInsider Buying: Osteopore Limited (ASX:OSX) Insider Purchases A$15,500.00 in StockSee More Headlines Industry, Sector and Symbol Stock ExchangeASX Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolASX:OSX CUSIPN/A CIKN/A Webwww.osteopore.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.99 Current Ratio9.60 Quick Ratio8.77 Sales & Book Value Annual Sales$1.11 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.05 per share Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Osteopore Frequently Asked Questions Who are Osteopore's key executives? Osteopore's management team includes the following people: Mr. Kei Wei Leong, Exec. Chairman (Age 46, Pay $23.05k)Mr. Khoon Seng Goh, Chief Exec. OfficerDr. Jing Lim, COO & CTOMs. Deborah Ho AGIA, B.Com., Company Sec. (Age 34) Who are some of Osteopore's key competitors? Some companies that are related to Osteopore include AddLife AB (publ) (ADDLF), Ambu A/S (AMBBY), Ansell (ANSLY), Ansell (ANSLF), Ansell (ANN), Austco Healthcare (AHC), BATM Advanced Communications (BTAVF), Carl Zeiss Meditec (CZMWY), Clover (CLV), Coloplast A/S (CLPBF), ConvaTec Group (CNVVY), Core One Labs (CLABF), Demant A/S (WILLF), Essilor International Société Anonyme (EI) and Fisher & Paykel Healthcare (FSPKF). View all of OSX's competitors. What is Osteopore's stock symbol? Osteopore trades on the ASX under the ticker symbol "OSX." How much money does Osteopore make? Osteopore (ASX:OSX) has a market capitalization of $0.00 and generates $1.11 million in revenue each year. This page (ASX:OSX) was last updated on 6/29/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here